Christopher Puterman
Papers
1
Total Citations
6
H-Index
1
About
Christopher Puterman is a clinical researcher whose work centers on improving the accuracy of cancer staging, with a particular focus on prostate cancer imaging. His major contributions lie in evaluating the diagnostic performance of advanced nuclear medicine techniques, specifically [18F]-fluorocholine PET/CT, for detecting lymph node metastases in intermediate and high-risk prostate cancer patients. In his most cited work, a 2021 retrospective study, Puterman rigorously assessed the accuracy of this imaging modality against the gold standard of extended lymph node dissection during robotic-assisted laparoscopic prostatectomy. This study, which has garnered 6 citations, provides critical, real-world data that challenges and refines clinical guidelines, highlighting the limitations of FCH PET/CT in primary staging. By directly comparing imaging results with surgical pathology, Puterman’s research offers actionable insights for urologists and oncologists, helping to prevent both under- and over-treatment. His work is a vital contribution to the ongoing effort to personalize cancer care, ensuring that patients receive the most appropriate and evidence-based staging before definitive treatment.
Research Focus
Key Achievements
Top Papers
- 1